Author

Shoshan Perek

Observed names: Perek, S., S. Perek, Shoshan Perk

Institutions: Carmel Medical Center, University of Haifa

Observed institutions: Technion – Israel Institute of Technology, Carmel Medical Center, University of Haifa

ORCID: 0000-0003-0928-7661

Observed ORCID: 0000-0003-0928-7661

OpenAlex ID: A5059515374

The effect of hindlimb immobilization on acid phosphatase, metalloproteinases and nuclear factor-κB in muscles of young and old rats

2004 · Marina Bar-Shai, Eli Carmeli, et al. · Mechanisms of Ageing and Development · 47

Bartonella henselae Endocarditis: An Usual Presentation of an Unusual Disease

2019 · Aasem Abu Shtaya, Shoshan Perek, et al. · European Journal of Case Reports in Internal Medicine · 12

PDF

Daratumumab and Romiplostim Combined Therapy for a Long-Standing Refractory Primary Immune Thrombocytopenia – Case Report

2025 · Ibrahim Zoubi, Amir Warwar, et al. · ImmunoTargets and Therapy · 6

PDF

Efficacy and safety of direct oral anticoagulants in patients with venous thrombosis and inherited thrombophilia

2025 · Amir Warwar, Iren Zargari, et al. · International Journal of Medical Sciences · 3

PDF

Risk of Major Bleeding with Antiplatelet and/or Anticoagulation Therapy in Inherited Factor XI Deficiency: Insights from Real-World Observations

2024 · Shanni Vaismann, Nili Stein, et al. · Thrombosis and Haemostasis · 3

Septic arthritis and smoldering myeloma

2015 · A. Silawy, G. Lavie, et al. · QJM · 2

[Actinomyces empyema treated with decortications].

2012 · Michal Shteinberg, Shoshan Perek, et al. · PubMed · 2

Impact of ASTCT Toxicity Grading System on Outcomes After CAR-T for Mature B-Cell Malignancies

2026 · Marina Gomez-Llobell, Silvia Escribano Serrat, et al. · Transplantation and Cellular Therapy · 1

ICANS mitigation in high-risk elderly patients treated with CD28 co-stimulatory anti-CD19 CAR-T cells using a standardization protocol: a pilot study

2026 · Gil Fridberg, Odelia Amit, et al. · Haematologica · 1

PDF

Assessing the correlation between patient and family reported outcome measures and multiple myeloma clinical parameters

2025 · Mouna Ballan-Haj, Kareem Midlej, et al. · Scientific Reports · 1

PDF

FGG p.Ser384Cys causes thrombin source-dependent underestimation of fibrinogen by Clauss assay: a familial case report

2026 · Emad Muhammad, Yarden Caspin, et al. · Thrombosis Update

PDF

Eligibility Matched Benchmarking of Second-Line Anti-CD19 Chimeric Antigen Receptor-T and Glofit-GemOx (STARGLO) Outcomes in Large B-Cell Lymphoma

2026 · Gil Fridberg, Odelia Amit, et al. · Transplantation and Cellular Therapy

The Use of Point-of-Care Hemoglobin Measurements in an Elderly Population with Hematological Disorders and Anemia

2026 · Ittai Appel, Liat Dizengoff, et al. · Hematology Reports

P-192: Patient reported outcome & family reported outcome and the most correlated clinical measures over one year of follow-Up

2022 · Kareem Midlig, Barbara Silverman, et al. · Clinical Lymphoma Myeloma & Leukemia

Supplementary Material for: Massive Gastrointestinal Bleeding from a Jejunal Dieulafoy Lesion: An Extraordinary Presentation

2019 · Saada, M., Perek, S., et al. · Figshare

Risk for Major Bleeding in Patients with Severe Factor XI Deficiency Treated with Aspirin and Clopidogrel

2017 · Shoshan Perek, Antonio Kotler, et al. · Blood

Salmonella peritoniti: Bir olgu nedeniyle

2000 · Mehmet Akif Büyükbeşe, Süleyman Özdemir, et al. · İnfeksiyon Dergisi

Works count: 17

Citation count: 78

H-index: 3

I10-index: 2